HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry
Jul 24, 2025 17:43 HKT |  |
|
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT |  |
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT |  |
|
Belgian Aircrew Completes MQ-9B Training
Jul 18, 2025 00:05 HKT |  |
|
Latest GA Autonomous Jet Demo Features Live Air-to-Air Engagement Capability
Jul 18, 2025 00:05 HKT | |
|
A New Transatlantic Partnership for European CCA
Jul 18, 2025 00:00 HKT | |
|
Cornerstone Robotics Signs MOU with NHG Health and NTU Singapore to Facilitate Accessibility of RAS to Patients in Singapore
Jul 17, 2025 18:45 HKT |  |
|
Global Sports Brand U.S. Polo Assn. Launches First Retail Store in Berlin, Germany
Jul 17, 2025 00:50 HKT |  |
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
Jul 16, 2025 15:00 HKT |  |
|
Formerra to Supply Foster Medical Compounds Across the Americas
Jul 15, 2025 22:50 HKT |  |
|
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Jul 15, 2025 16:00 HKT |  |
|
Cornerstone Robotics Launches First Clinical Evaluation of its Hong Kong-Developed Surgical Robotic System in UK
Jul 09, 2025 20:32 HKT | |
|
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
Jul 04, 2025 18:59 HKT | |
|
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 21:27 HKT |  |
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange
Jun 25, 2025 18:00 HKT | |
|
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology
Jun 23, 2025 21:00 HKT |  |
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT |  |
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT | |
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 09, 2025 12:52 HKT | |
|
Traditional Chinese Medicine Consumption Shows Promising Outlook, with Neautus's Market Leadership Becoming Increasingly Evident
Jun 03, 2025 16:56 HKT | |
|